SARS-CoV-2 vaccine research and development: conventional vaccines and biomimetic nanotechnology strategies
The development of a massively producible vaccine against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a novel coronavirus, is essential for stopping the current coronavirus disease (COVID-19) pandemic. A vaccine must stimulate effective antibody and T cell responses in vivo to indu...
- Autores:
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12714
- Acceso en línea:
- https://doi.org/10.1016/j.ajps.2020.08.001
http://hdl.handle.net/20.500.12010/12714
- Palabra clave:
- SARS-CoV-2
COVID-19
Vaccine
Biomimetic nanotechnology
Virus-like nanoparticles
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Abierto (Texto Completo)